Neurokine Pharmaceuticals Inc Stock Other OTC
Equities
CAC611561100
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
May. 01 | BetterLife Pharma Advances IND-enabling Studies For BETR-001 | MT |
Apr. 03 | BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 13.32M |
---|---|---|---|---|---|
Net income 2022 | -12M | Net income 2023 | -9M | EV / Sales 2022 | - |
Net Debt 2022 | 139K | Net Debt 2023 | 71.69K | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.26
x | P/E ratio 2023 |
-1.36
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.36% |
Managers | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 10-12-25 |
Chief Operating Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 07-09-16 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 20-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 15-02-04 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.76% | 22.25B | |
-14.77% | 21.68B | |
-9.00% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |